CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cian Healthcare Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cian Healthcare Ltd
1st & 2nd Floor Premdeep Building
Above latur urban co-op. Bank Ltd. Lulla
Pune, 411040  India Ticker: 542678542678
On 6/12/2024, an Insolvency application filed against Cian Healthcare Ltd by its operational creditor Shreeji Pharmachem was admitted by the National Company Law Tribunal, Mumbai bench
Business Summary
Cian Healthcare Limited is an India-based company, which is engaged in manufacturing of Pharmaceuticals, OTCs, Supplements and Veterinary products. The Company is engaged in manufacturing multiple lines-tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets. Its portfolio comprises gynaecology, haematinic, cardio- diabetic, orthopaedic, paediatric, derma-cosmetic, antibiotic, CNS, vitamins and nutrient products. It is also engaged in the business of manufacturing cosmetic products. The Company's services include pharma visual aid (book or spiral) design and printing, pharma literature design and printing, pharma monographs/ reference folders, LBL’s/ reminder cards design, pharma poster design, pharmaceutical carton/ catch cover designing, corporate identity design, advertising design, product information leaflet, and brand communication. The Company's subsidiary includes Dr. Smith Biotech Private Limited.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer KalyaniChordia 1/31/2025 1/31/2025
Company Secretary and Compliance Officer Bhushan R.Kulkarni 5/10/2024 5/10/2024
Managing Director, Whole-Time Director Suraj S.Zanwar 48 1/7/2003 1/7/2003
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 257 (As of 3/31/2024)
Outstanding Shares: 24,995,764 (As of 9/30/2024)
Stock Exchange: BOM


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, October 31, 2025